CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 11 enrolled
Drug / intervention
APSbiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02262364
NCT02262364Phase 1Completed
CompareCT.gov

A Pilot Study of a Single Intra-articular Injection of Autologous Protein Solution in Patients With Knee Osteoarthritis

Zimmer Biomet·interventional·Posted Oct 13, 2014·Updated Feb 15, 2019

In Brief

A Phase 1 clinical trial evaluating APS for Osteoarthritis, Knee. Completed, enrolled 11 participants across 1 site.

Detailed Summary

The primary objective of this study is to assess the safety of a single injection of APS.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Knee
CountriesUnited States
CollaboratorsBiomet Biologics, LLC

Timeline

Phase 1CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 13, 2014
Enrollment StartNov 1, 2014
Primary CompletionOct 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 11.7 years ago

Interventions

APSbiological

See above